Parallel Advisors, LLC Ngm Biopharmaceuticals Inc Transaction History

Parallel Advisors, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 20, 2024	BUY	$3.72 - $5.4 $2,961 - $4,298	796 New	796 $3,000
Q1 2023 Apr 25, 2023	BUY	$3.72 - $5.4 $2,801 - $4,066	753 Added 1751.16%	796 $3,000
Q4 2022 Feb 03, 2023	BUY	$3.41 - $12.93 $61 - $232	18 Added 72.0%	43 $0
Q3 2022 Nov 10, 2022	SELL	$12.59 - $17.67 $289 - $406	-23 Reduced 47.92%	25 $0
Q2 2022 Aug 01, 2022	BUY	$10.58 - $17.5 $507 - $840	48 New	48 $1,000
Q1 2022 Apr 28, 2022	SELL	$13.81 - $18.6 $1,546 - $2,083	-112 Closed	0 $0
Q4 2021 Jan 20, 2022	SELL	$17.26 - $22.02 $1,553 - $1,981	-90 Reduced 44.55%	112 $2,000
Q3 2021 Nov 02, 2021	BUY	$20.15 - $26.19 $4,070 - $5,290	202 New	202 $4,000

2.6M

300

Ticker NGM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 80,365,904
Description
NGM Biopharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of novel therapeutics to treat liver and metabolic diseases, retinal diseases, and cancer. The company's product candidates include Aldafermin, an engineered analog of human hormone fibroblast growth factor 19, which is in Phase IIb clinical trial...

Get notified when there are updates to the investment portfolio of Parallel Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Parallel Advisors, LLC with notifications on news.